{"id": "1349569705221136389", "creation": 1610597466.0, "user_id": "65890224", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 1, "quote_count": 0}}, "text": "The safety and immunogenicity profiles of the Johnson &amp; Johnson #COVID19 #vaccine support further development of this vaccine candidate. Neutralizing-antibody titers against wild-type virus were detected in 90% or more of all participants on day 29 after\u2026https://t.co/2wiiSya9Jy", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE"]}